Re: Series B Warrant Exercise AgreementSeries B Warrant Exercise Agreement • December 21st, 2023 • NovaBay Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledDecember 21st, 2023 Company IndustryNovaBay Pharmaceuticals, Inc. (the “Company”) previously issued and delivered to you (“Holder” or “you” or “your”) the Company’s Series B-1 warrants (the “Series B-1 Warrants”) to purchase Company common stock, par value $0.01 per share (“Common Stock”) and the Series B-2 warrants (the “Series B-2 Warrants” and together with the Series B-1 Warrants, the “Series B Warrants”) to purchase Common Stock that were issued to you pursuant to a Securities Purchase Agreement, dated April 27, 2023 (the “Purchase Agreement”).